Literature DB >> 4601861

[Acute lupus erythematosus with total absence of the C4 fraction of complement].

G Hauptmann, E Grosshans, E Heid, S Mayer, A Basset.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4601861

Source DB:  PubMed          Journal:  Nouv Presse Med        ISSN: 0301-1518


× No keyword cloud information.
  8 in total

1.  Genetic polymorphism of serum complement components in the chimpanzee.

Authors:  D Raum; H Balner; B H Petersen; C A Alper
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

Review 2.  Inherited deficiencies of complement proteins in man.

Authors:  C A Alper; F S Rosen
Journal:  Springer Semin Immunopathol       Date:  1984

3.  The location of C2, C4, and BF relative to HLA-B and HLA-D.

Authors:  D D Raum; Z L Awdeh; D Glass; E Yunis; C A Alper
Journal:  Immunogenetics       Date:  1981-03-01       Impact factor: 2.846

4.  The activation of the C3b feedback cycle with human complement components. I. Through the classical pathway.

Authors:  L W Mak; P J Lachmann; J Majewski
Journal:  Clin Exp Immunol       Date:  1977-11       Impact factor: 4.330

5.  A case of deficiency of the seventh component of complement in man. Biological properties of a C7-deficient serum and description of a C7-inactivating principle.

Authors:  B Wellek; W Opferkuch
Journal:  Clin Exp Immunol       Date:  1975-02       Impact factor: 4.330

6.  Recurrent bacterial meningitis in patients with genetic defects of terminal complement components.

Authors:  M R Haeney; R A Thompson; J Faulkner; P Mackintosh; A P Ball
Journal:  Clin Exp Immunol       Date:  1980-04       Impact factor: 4.330

7.  A second case of human C3b inhibitor (KAF) deficiency.

Authors:  R A Thompson; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

8.  Complement-human histocompatibility antigen haplotypes in C2 deficiency.

Authors:  Z L Awdeh; D D Raum; D Glass; V Agnello; P H Schur; R B Johnston; E W Gelfand; M Ballow; E Yunis; C A Alper
Journal:  J Clin Invest       Date:  1981-02       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.